Kratom and the FDA: Regulatory History, Research and Product Claims

Kratom is Mitragyna speciosa, a tree native to Southeast Asia. Its leaves contain several alkaloids, including mitragynine. Discussions about the plant often mix together drug scheduling, product regulation and research findings. These are related questions, but they are not interchangeable.

The 2016 Proposal Was Withdrawn

In 2016, the DEA proposed temporarily placing mitragynine and 7-hydroxymitragynine in Schedule I. It withdrew that notice in October 2016. The proposal did not become an alternative “Schedule I instead of a ban” outcome, as an earlier version of this article incorrectly suggested. See the official withdrawal notice.

FDA Approval and Marketing Are Separate Questions

The FDA’s kratom page states that there are no legally marketed FDA-approved kratom drug products. It also describes the agency’s position that kratom cannot lawfully be marketed as a dietary supplement or added to conventional foods. A state consumer protection law or manufacturing qualification does not override those federal positions.

Removing medical claims does not, by itself, establish that a product complies with every applicable requirement. A research citation also does not turn a retail product into an approved treatment.

Reports of Harm and What They Establish

Reports involving multiple substances can make the contribution of any one ingredient uncertain. That uncertainty should be acknowledged without declaring that kratom could never contribute to harm. Product composition, amounts, contaminants, other substances and individual health circumstances matter.

Our research guide distinguishes laboratory findings, surveys and human research. Personal reports are useful context but do not establish clinical safety or treatment effectiveness.

Leaf Kratom and Enhanced 7-OH

Natural leaf products and products concentrated or enhanced with 7-hydroxymitragynine should not be treated as equivalent. Our founder reports that powder tests he has reviewed over eleven years have not exceeded 0.01% 7-OH. This is a historical observation, not a verified statistical average, a universal detection limit or a guarantee for every batch.

See our 7-OH information page and the FDA’s 7-OH resource for further context.

Check Current Requirements

Use current official federal, state and local records when researching rules for a particular product and location. The 2016 withdrawal does not establish present-day legality for every formulation or jurisdiction.